OrthoWing / OrthoKontrol AG
Digital compliance platform unlocking clear aligner therapy for teenagers
| Deal Type | Equity |
|---|---|
| Sector | HealthTech & Digital Health |
| Geography | Switzerland / Global |
| Stage / Vintage | Market launch planned Q3 2026 |
| Total Fundraise | CHF 1.2M |
| Minimum Ticket | N/D |
Opportunity Overview
OrthoKontrol AG is developing OrthoWing, a digital health app and microsensor that monitors compliance in orthodontic aligner therapy for teenagers. The problem is that teenagers want clear aligners, but doctors often hesitate because non-compliance can create treatment failures, increased treatment time, higher costs and litigation risk. OrthoWing gives patients and parents reminders and gamification, while orthodontists receive wear-time evidence and incompliance alerts. The company states the technology is ready for use, a patient study has started, patents are active in major markets, and market launch is planned for Q3 2026. The round is intended to complete software development, enter the market and establish a strategic partnership.
Key Highlights
- Digital health app plus smallest-in-market microsensor for reliable wear-time measurement.
- Targets an underserved teenager aligner segment and a cited USD 11B addressable opportunity by 2030 if teenagers can be served.
- Technology ready for use, patient study started and patent protection active in major markets.
- 20+ CH / D orthodontists are described as ready to buy, with five KOLs already invested.
- CHF 1.2M ask to finish software development, go to market and establish a strategic investor partnership.
GCC Relevance
GCC fit is likely through premium dentistry, orthodontic clinics and private healthcare groups. The materials do not cite current Gulf distribution, but the consumer-driven aligner market and high private-pay dental activity may create a relevant regional commercial angle.